Effects of hormone receptor status on patient clinic and survival in HER2 positive breast cancer.
Mukaddes YılmazEda ErdişMahmut UçarNecla DemirCelal AlandağBirsen YücelPublished in: Japanese journal of clinical oncology (2024)
Both clinicopathologic features and OS outcomes of HR-negative patients were worse than those of HR-positive patients.